November 10, 2025
Pfizer wins $10 billion bidding war for Metsera
U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk.
Read More
November 10, 2025
Coinbase, Robinhood highlight dismal week for crypto stocks
Shares of crypto-focused companies have tumbled last week, capping a bruising stretch for the digital asset sector marked by renewed macroeconomic fears and lingering fallout from October’s liquidity crunch and mixed corporate earnings. Coinbase, Block and Robinhood fell between 11 and 14%.
Read More
November 10, 2025
Government shutdown fuels anxiety
U.S. consumer sentiment slumped to near a 3.5 year low in early November as households across the political spectrum worried about the economic fallout from the longest government shutdown in history, which has caused disruptions ranging from food benefit payments to grounded flights.
Read More
November 7, 2025
The U.S. dollar fell against the Swiss franc
The U.S. dollar fell against the euro and Swiss franc for a second straight session as data showed weakness in the U.S. labor market, increasing expectations of another rate cut this year. Meanwhile, sterling rose after the Bank of England kept rates unchanged ahead of this month’s budget.
Read More
November 7, 2025
Wall Street ends lower on tech valuations, economic jitters
U.S. stocks closed in negative territory, with a resumption of Tuesday’s tech selloff as investors contended with mounting economic uncertainty and stretched valuations. All three major U.S. equity indexes lost ground as risk appetite was dampened by worries over inflated stock prices
Read More
November 7, 2025
Airbnb third-quarter profit, revenue get a lift from strong international demand
Vacation rental firm Airbnb posted higher third-quarter profit and revenue, helped by strong bookings in markets such as Latin America and Asia Pacific. Shares of the company rose 4.6% after the bell.
Read More
